Repaglinide versus sulfonylurea in combination with bedtime NPH insulin in patients with type 2 diabetes with secondary failure to oral treatment

被引：0

|

作者：

Strojek, K

Polaszewska-Muszynska, M

Krassowski, J

Gumprecht, J

Rudzki, H

Olejniczak, H

Nazar, M

机构：

来源：

DIABETES | 2003年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A135 / A135

页数：1

相关论文

共 50 条

[21] Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes
de luis, DA
Aller, R
Cuellar, L
Terroba, C
Ovalle, H
Izaola, O
Romero, E
[J]. DIABETES CARE, 2001, 24 (10) : 1844 - 1845
[22] Metformin superior to repaglinide when combined with nocturnal NPH insulin in patients with type 2 diabetes
Furlong, NJ
Hulme, SA
O Brien, SV
Hardy, KJ
[J]. DIABETES, 2002, 51 : A470 - A470
[23] THE COMBINATION OF INSULIN AND SULFONYLUREAS IN THE TREATMENT OF TYPE-2 DIABETES WITH SECONDARY FAILURE OF SULFONYLUREA THERAPY - LONG-TERM RESULTS
LOTZ, N
BACHMANN, W
LADIK, T
MEHNERT, H
[J]. KLINISCHE WOCHENSCHRIFT, 1988, 66 (21): : 1079 - 1084
[24] MORNING VERSUS BEDTIME NPH INSULIN IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS
SEIGLER, DE
OLSSON, M
SKYLER, JS
[J]. DIABETOLOGIA, 1987, 30 (07) : A581 - A581
[25] COST EFFECTIVENESS EVALUATION OF CANAGLIFLOZIN IN COMBINATION WITH METFORMIN AND SULFONYLUREA IN COMPARISON TO NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN POLAND
Szmurlo, D.
Drzal, R.
Plisko, R.
Schubert, A.
Skrzekowska-Baran, I
[J]. VALUE IN HEALTH, 2014, 17 (07) : A351 - A351
[26] Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes
Raskin, P.
[J]. DIABETES OBESITY & METABOLISM, 2008, 10 (12): : 1167 - 1177
[27] COMPARISON OF BEDTIME INSULIN GLARGINE VERSUS TWICE-DAILY NPH AMONG INNER CITY ETHNIC MINORITY TYPE 2 DIABETIC PATIENTS UNCONTROLLED ON BEDTIME NPH AND ORAL AGENTS
Hsia, S. H.
[J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (01) : 252 - 252
[28] Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes
Sargin, H
Sargin, M
Altuntas, Y
Sengül, AM
Orbay, E
Seber, S
Uçak, S
Yayla, A
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 62 (02) : 79 - 86
[29] The efficacy of repaglinide administered in combination with bedtime NPH-insulin in patients with type 2 diabetes. A randomized, semi-blinded, parallel-group, multi-centre trial
Landin-Olsson, M
Brogard, JMM
Eriksson, J
Rasmussen, M
Clauson, P
[J]. DIABETES, 1999, 48 : A117 - A117
[30] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
Pan, Chang-Yu
Sinnassamy, Patrick
Chung, Kab-Do
Kim, Kwang-Won
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118

← 1 2 3 4 5 →